SCHEMBL7552151

SCHEMBL7552151

O=C(O)N1CCCc2cc(C(F)(F)F)ccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.63
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
LMNA P02545 2/20 0.47
NR1H3 Q13133 2/20 0.45
NR3C1 P04150 1/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
RAB9A P51151 1/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
GPBAR1 Q8TDU6 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PDK1 Q15118 3/20 0.43
PDK2 Q15119 3/20 0.43
PDK3 Q15120 3/20 0.43
PDK4 Q16654 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7382818 0.96 NOTUM (0.62) NOTUMHTR2AHTR2CLMNANR1H3
SCHEMBL28129591 0.95 NOTUM (0.58) NOTUMHTR2AHTR2CLMNANR1H3
SCHEMBL30681440 0.91 NOTUM (0.76) NOTUMHTR2AHTR2CLMNACYP2C9
SCHEMBL27544652 0.88 CNR2 (0.53) NOTUMHTR2AHTR2CHDAC1HDAC6
SCHEMBL24011079 0.87 NOTUM (0.84) NOTUMLMNASMN1; SMN2HTT
SCHEMBL3653813 0.83 NOTUM (0.61) NOTUMHTR2AHTR2CLMNAKDM4E
SCHEMBL26763830 0.83 NOTUM (0.61) NOTUMHTR2AHTR2CLMNANR3C1
SCHEMBL5696394 0.81 NOTUM (0.59) NOTUMHTR2AHTR2CLMNANR3C1
SCHEMBL6752845 0.81 NOTUM (0.59) NOTUMHTR2AHTR2CLMNANR3C1
SCHEMBL30767099 0.81 NOTUM (0.59) NOTUMHTR2AHTR2CLMNANR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3833336-A1 METHODS FOR DELAYING OCCURRENCE OF NEW-ONSET TYPE 2 DIABETES AND FOR SLOWING PROGRESSION OF AND TREATING TYPE 2 DIABETES DalCor Pharma UK Ltd Leatherhead, Zug Branch (CH) 2021-06-16 EP disclosed
WO-2020030814-A1 METHODS FOR DELAYING OCCURRENCE OF NEW-ONSET TYPE 2 DIABETES AND FOR SLOWING PROGRESSION OF AND TREATING TYPE 2 DIABETES DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH (CH) 2020-02-13 WO disclosed
EP-0966473-B1 THIAZOLOBENZOHETEROCYCLES, PREPARATION AND MEDICINES CONTAINING SAME AVENTIS PHARMA SA (FR) 2002-07-24 EP disclosed
EP-0966473-A1 THIAZOLOBENZOHETEROCYCLES, PREPARATION AND MEDICINES CONTAINING SAME Aventis Pharma S.A. (FR) 1999-12-29 EP disclosed
WO-1998038194-A1 THIAZOLOBENZOHETEROCYCLES, PREPARATION AND MEDICINES CONTAINING SAME RHONE-POULENC RORER S.A. (FR) 1998-09-03 WO disclosed